Bioverge
Join Neil Littman on The Bioverge Podcast as he explores the intersection of bio x tech and features the entrepreneurs, investors, and industry leaders who are revolutionizing healthcare and bringing science fiction to life.
Latest episodes
Aug 18, 2021 • 56min
Evolving Failures in an Evolving Pandemic and What Needs to Be Done
Eric Topol, founder and director of the Scripps Research Translational Institute, sits down with Neil to discuss the COVID-19 delta variant, our failures to evolve with the virus, and what steps need to be taken to combat the ongoing pandemic.
Aug 1, 2021 • 40min
Bridging the Translational Science Divide
Pete Schultz, CEO of Scripps Research, sits down with Neil to discuss his efforts to create a self-sustaining nonprofit drug discovery and development institute and it’s work to advance small molecule regenerative therapies from the lab to the clinic.
Jul 15, 2021 • 42min
Why the FDA Was Right to Approve Biogen's Aduhelm
James Valentine, an attorney with Hyman, Phelps & McNamara specializing in regulatory law, sits down with Neil to discuss the FDA’s accelerated approval of Biogen’s Aduhelm for Alzheimer’s disease and offers a contrarian take on the controversy.
Jul 1, 2021 • 54min
Democratizing Entrepreneurship
Juan Scarlett, managing director of OneValley Ventures, sits down with Neil to discusses OneValley's efforts to democratize entrepreneurship and his approach investing in pre-seed and seed funding rounds.
Jun 15, 2021 • 41min
Managing the Challenges of Scaling Cell and Gene Therapies
Amy DuRoss, co-founder and CEO of Vineti, sits down with Neil to discuss how the company’s platform technology addresses the unique supply chain management challenges of cell and gene therapy companies.
Jun 1, 2021 • 45min
Advancing a Pipeline of Off-The-Shelf Cell Therapies
Brian Culley, CEO of Lineage Cell Therapeutics, sits down with Neil to discuss his company’s efforts to develop off-the-shelf cell therapies to treat degenerative retinal disease, spinal cord injury, and cancer.
May 14, 2021 • 56min
Weighing the Strengths and Weakness of Various COVID-19 Vaccines
Craig Laferrière head of vaccine development for Novateur Ventures, joins Neil to discuss the relative strengths and weaknesses of the different COVID-19 vaccines in use and in development.
May 3, 2021 • 40min
Improving Epilepsy Outcomes with Digital Health Technology
Rachel Kuperman, CEO of Eysz, sits down with Neil to discuss her company’s efforts to develop a digital health platform using passive eye-movements as input to measure, diagnose, and predict neurological disease starting with epilepsy.
Apr 15, 2021 • 32min
Removing Toxins from Cerebrospinal Fluid to Treat Neurodegenerative Diseases
Anthony DePasqua, CEO of EnClear Therapies, sits down with Neil to discuss the company’s technology in development to remove toxic proteins from cerebrospinal spinal fluid to treat patients with ALS and other neurodegenerative conditions.
Apr 1, 2021 • 57min
Decoding the World
Arvind Gupta, founder of IndieBio and co-lead of the engineering biology practice at the venture capital firm Mayfield, and Po Bronson, author and managing director and partner at IndieBio, sit down with Neil to discuss their new book Decoding the World, IndieBio, and the future of biotech.
